Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p103 has 88 genes in the original annotation. Currently, there are 62 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
5532	PPP3CB	CALNA2 \| CALNB \| CNA2 \| PP2Bbeta	protein phosphatase 3 catalytic subunit beta	10q22.2
1147	CHUK	IKBKA \| IKK-alpha \| IKK1 \| IKKA \| NFKBIKA \| TCF16	conserved helix-loop-helix ubiquitous kinase	10q24-q25
355	FAS	ALPS1A \| APO-1 \| APT1 \| CD95 \| FAS1 \| FASTM \| TNFRSF6	Fas cell surface death receptor	10q24.1
5970	RELA	NFKB3 \| p65	v-rel avian reticuloendotheliosis viral oncogene homolog A	11q13
8772	FADD	GIG3 \| MORT1	Fas associated via death domain	11q13.3
23052	ENDOD1	-	endonuclease domain containing 1	11q21
330	BIRC3	AIP1 \| API2 \| CIAP2 \| HAIP1 \| HIAP1 \| MALT2 \| MIHC \| RNF49 \| c-IAP2	baculoviral IAP repeat containing 3	11q22
472	ATM	AT1 \| ATA \| ATC \| ATD \| ATDC \| ATE \| TEL1 \| TELO1	ATM serine/threonine kinase	11q22-q23
11213	IRAK3	ASRT5 \| IRAKM	interleukin 1 receptor associated kinase 3	12q14.3
4792	NFKBIA	IKBA \| MAD-3 \| NFKBI	NFKB inhibitor alpha	14q13
207	AKT1	AKT \| CWS6 \| PKB \| PKB-ALPHA \| PRKBA \| RAC \| RAC-ALPHA	v-akt murine thymoma viral oncogene homolog 1	14q32.32
23533	PIK3R5	F730038I15Rik \| FOAP-2 \| P101-PI3K \| p101	phosphoinositide-3-kinase regulatory subunit 5	17p13.1
7157	TP53	BCC7 \| LFS1 \| P53 \| TRP53	tumor protein p53	17p13.1
9020	MAP3K14	FTDCR1B \| HS \| HSNIK \| NIK	mitogen-activated protein kinase kinase kinase 14	17q21
5573	PRKAR1A	ACRDYS1 \| ADOHR \| CAR \| CNC \| CNC1 \| PKR1 \| PPNAD1 \| PRKAR1 \| TSE1	protein kinase cAMP-dependent type I regulatory subunit alpha	17q24.2
596	BCL2	Bcl-2 \| PPP1R50	B-cell CLL/lymphoma 2	18q21.3
208	AKT2	HIHGHH \| PKBB \| PKBBETA \| PRKBB \| RAC-BETA	v-akt murine thymoma viral oncogene homolog 2	19q13.1-q13.2
5296	PIK3R2	MPPH \| MPPH1 \| P85B \| p85 \| p85-BETA	phosphoinositide-3-kinase regulatory subunit 2	19q13.2-q13.4
581	BAX	BCL2L4	BCL2-associated X protein	19q13.3-q13.4
4803	NGF	Beta-NGF \| HSAN5 \| NGFB	nerve growth factor	1p13.1
5567	PRKACB	PKA C-beta \| PKACB	protein kinase cAMP-activated catalytic subunit beta	1p31.1
8503	PIK3R3	p55 \| p55-GAMMA \| p55PIK	phosphoinositide-3-kinase regulatory subunit 3	1p34.1
5293	PIK3CD	APDS \| IMD14 \| P110DELTA \| PI3K \| p110D	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta	1p36.2
842	CASP9	APAF-3 \| APAF3 \| ICE-LAP6 \| MCH6 \| PPP1R56	caspase 9	1p36.21
1676	DFFA	DFF-45 \| DFF1 \| ICAD	DNA fragmentation factor subunit alpha	1p36.3-p36.2
4914	NTRK1	MTC \| TRK \| TRK1 \| TRKA \| Trk-A \| p140-TrkA	neurotrophic tyrosine kinase, receptor, type 1	1q21-q22
10000	AKT3	MPPH \| MPPH2 \| PKB-GAMMA \| PKBG \| PRKBG \| RAC-PK-gamma \| RAC-gamma \| STK-2	v-akt murine thymoma viral oncogene homolog 3	1q44
598	BCL2L1	BCL-XL/S \| BCL2L \| BCLX \| Bcl-X \| PPP1R52	BCL2 like 1	20q11.21
637	BID	FP497	BH3 interacting domain death agonist	22q11.1
1439	CSF2RB	CD131 \| CDw131 \| IL3RB \| IL5RB \| SMDP5	colony stimulating factor 2 receptor beta common subunit	22q13.1
5534	PPP3R1	CALNB1 \| CNB \| CNB1	protein phosphatase 3 regulatory subunit B, alpha	2p15
3554	IL1R1	CD121A \| D2S1473 \| IL-1R-alpha \| IL1R \| IL1RA \| P80	interleukin 1 receptor type 1	2q12
3552	IL1A	IL-1A \| IL1 \| IL1-ALPHA \| IL1F1	interleukin 1 alpha	2q14
3553	IL1B	IL-1 \| IL1-BETA \| IL1F2	interleukin 1 beta	2q14
841	CASP8	ALPS2B \| CAP4 \| Casp-8 \| FLICE \| MACH \| MCH5	caspase 8	2q33-q34
843	CASP10	ALPS2 \| FLICE2 \| MCH4	caspase 10	2q33-q34
9941	EXOG	ENDOGL1 \| ENDOGL2 \| ENGL \| ENGL-a \| ENGL-b \| ENGLA \| ENGLB	endo/exonuclease (5'-3'), endonuclease G-like	3p21.3
5576	PRKAR2A	PKR2 \| PRKAR2	protein kinase cAMP-dependent type II regulatory subunit alpha	3p21.3-p21.2
4615	MYD88	MYD88D	myeloid differentiation primary response 88	3p22
5291	PIK3CB	P110BETA \| PI3K \| PI3KBETA \| PIK3C1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta	3q22.3
8743	TNFSF10	APO2L \| Apo-2L \| CD253 \| TL2 \| TNLG6A \| TRAIL	tumor necrosis factor superfamily member 10	3q26
5290	PIK3CA	CLOVE \| CWS5 \| MCAP \| MCM \| MCMTC \| PI3K \| p110-alpha	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	3q26.3
3556	IL1RAP	C3orf13 \| IL-1RAcP \| IL1R3	interleukin 1 receptor accessory protein	3q28
4790	NFKB1	CVID12 \| EBP-1 \| KBF1 \| NF-kB1 \| NF-kappa-B \| NF-kappaB \| NFKB-p105 \| NFKB-p50 \| NFkappaB \| p105 \| p50	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1	4q24
5530	PPP3CA	CALN \| CALNA \| CALNA1 \| CCN1 \| CNA1 \| PPP2B	protein phosphatase 3 catalytic subunit alpha	4q24
839	CASP6	MCH2	caspase 6	4q25
836	CASP3	CPP32 \| CPP32B \| SCA-1	caspase 3	4q34
5295	PIK3R1	AGM7 \| GRB1 \| IMD36 \| p85 \| p85-ALPHA	phosphoinositide-3-kinase regulatory subunit 1	5q13.1
3562	IL3	IL-3 \| MCGF \| MULTI-CSF	interleukin 3	5q31.1
7124	TNF	DIF \| TNF-alpha \| TNFA \| TNFSF2 \| TNLG1F	tumor necrosis factor	6p21.3
8737	RIPK1	RIP \| RIP-1 \| RIP1	receptor interacting serine/threonine kinase 1	6p25.2
5575	PRKAR1B	PRKAR1	protein kinase cAMP-dependent type I regulatory subunit beta	7p22
5577	PRKAR2B	PRKAR2 \| RII-BETA	protein kinase cAMP-dependent type II regulatory subunit beta	7q22
3551	IKBKB	IKK-beta \| IKK2 \| IKKB \| IMD15 \| NFKBIKB	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta	8p11.2
8797	TNFRSF10A	APO2 \| CD261 \| DR4 \| TRAILR-1 \| TRAILR1	tumor necrosis factor receptor superfamily member 10a	8p21
5533	PPP3CC	CALNA3 \| CNA3 \| PP2Bgamma	protein phosphatase 3 catalytic subunit gamma	8p21.3
5568	PRKACG	BDPLT19 \| KAPG \| PKACg	protein kinase cAMP-activated catalytic subunit gamma	9q13
7186	TRAF2	MGC:45012 \| TRAP \| TRAP3	TNF receptor associated factor 2	9q34
2021	ENDOG	-	endonuclease G	9q34.1
3563	IL3RA	CD123 \| IL3R \| IL3RAY \| IL3RX \| IL3RY \| hIL-3Ra	interleukin 3 receptor subunit alpha	Xp22.3 or Yp11.3
331	XIAP	API3 \| BIRC4 \| IAP-3 \| ILP1 \| MIHA \| XLP2 \| hIAP-3 \| hIAP3	X-linked inhibitor of apoptosis	Xq25
3654	IRAK1	IRAK \| pelle	interleukin 1 receptor associated kinase 1	Xq28